Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers Diabetes Mellitus, Type 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04152915
What this trial is testing

A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens

Who this might be right for
Healthy VolunteersDiabetes Mellitus, Type 2
Novo Nordisk A/S 68
Early research (Phase 1)Study completedNCT00933530
What this trial is testing

A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers

Who this might be right for
Diabetes Mellitus, Type 2Healthy Volunteer
Sirtris, a GSK Company 43
Early research (Phase 1)Study completedNCT03776227
What this trial is testing

A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions

Who this might be right for
Type 2 Diabetes MellitusHealthy Subjects
Sanofi 66
Early research (Phase 1)UnknownNCT05996380
What this trial is testing

Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes

Who this might be right for
T2DM
Jiangsu HengRui Medicine Co., Ltd. 52
Early research (Phase 1)Looking for participantsNCT07778524
What this trial is testing

Alpelisib Challenge Test (ACT)

Who this might be right for
Insulin ResistanceType 2 DiabetesObesity & Overweight+1 more
Columbia University 15
Early research (Phase 1)Study completedNCT05816759
What this trial is testing

Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150

Who this might be right for
Type 2 Diabetes
Chong Kun Dang Pharmaceutical 32
Early research (Phase 1)Study completedNCT01156246
What this trial is testing

Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers

Who this might be right for
Healthy
AstraZeneca 18
Early research (Phase 1)Study completedNCT00933062
What this trial is testing

Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 10
Testing effectiveness (Phase 2)Study completedNCT01407003
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals 138
Early research (Phase 1)Study completedNCT02250222
What this trial is testing

Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ligand Pharmaceuticals 48
Not applicableActive Not RecruitingNCT06246851
What this trial is testing

BCG Revaccination Study in Diabetic and Non-Diabetic Adults

Who this might be right for
Tuberculosis
University of Oxford 36
Early research (Phase 1)Looking for participantsNCT06562907
What this trial is testing

Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Weight Management
Gilead Sciences 134
Early research (Phase 1)Study completedNCT01751399
What this trial is testing

A Single Dose Study of LY2605541 in Participants With Liver Impairment

Who this might be right for
Healthy VolunteersHepatic InsufficiencyDiabetes Mellitus, Type 2
Eli Lilly and Company 35
Early research (Phase 1)Study completedNCT04259801
What this trial is testing

First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes

Who this might be right for
Healthy VolunteersOverweightObesity+1 more
Novo Nordisk A/S 152
Early research (Phase 1)UnknownNCT04322032
What this trial is testing

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389

Who this might be right for
Type 2 Diabetes
Chong Kun Dang Pharmaceutical 34
Early research (Phase 1)WithdrawnNCT01305551
What this trial is testing

BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States

Who this might be right for
Type 2 Diabetes
AstraZeneca
Early research (Phase 1)Study completedNCT06495931
What this trial is testing

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

Who this might be right for
Type 2 Diabetes Mellitus
Shandong Suncadia Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT01780051
What this trial is testing

A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components

Who this might be right for
Diabetes Mellitus, Type 2
Dalim BioTech Co., Ltd. 48
Early research (Phase 1)Study completedNCT03232983
What this trial is testing

LY900014 Formulation at Different Injection Sites in Healthy Participants

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 28
Very early researchStudy completedNCT03479671
What this trial is testing

Low Dose Fat-Induced Insulin Resistance

Who this might be right for
Diabetes Mellitus, Type 2Insulin ResistanceInsulin Sensitivity
University of Pennsylvania 9
Next Page